The Function and Therapeutic Potential of Circular RNA in Cardiovascular Diseases

Cardiovasc Drugs Ther. 2023 Feb;37(1):181-198. doi: 10.1007/s10557-021-07228-5. Epub 2021 Jul 16.

Abstract

Circular RNA (circRNA) has a closed-loop structure, and its 3' and 5' ends are directly covalently connected by reverse splicing, which is more stable than linear RNA. CircRNAs usually possess microRNA (miRNA) binding sites, which can bind miRNAs and inhibit miRNA function. Many studies have shown that circRNAs are involved in the processes of cell senescence, proliferation and apoptosis and a series of signalling pathways, playing an important role in the prevention and treatment of diseases. CircRNAs are potential biological diagnostic markers and therapeutic targets for cardiovascular diseases (CVDs). To identify biomarkers and potential effective therapeutic targets without toxicity for heart disease, we summarize the biogenesis, biology, characterization and functions of circRNAs in CVDs, hoping that this information will shed new light on the prevention and treatment of CVDs.

Keywords: Cardiovascular disease (CVD); Circular RNA (circRNA); Potential biological diagnostic markers; microRNA (miRNA) sponges.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / therapy
  • Heart Diseases*
  • Humans
  • MicroRNAs* / genetics
  • MicroRNAs* / therapeutic use
  • RNA / genetics
  • RNA, Circular / genetics

Substances

  • RNA, Circular
  • RNA
  • MicroRNAs
  • Biomarkers